21 – 30 of 100
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Immune checkpoint inhibitors in Wilms' tumor and Neuroblastoma : What now?
- Contribution to journal › Article
- 2020
-
Mark
ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma
- Contribution to journal › Article
-
Mark
Discovery of epi-enprioline as a novel drug for the treatment of vincristine resistant neuroblastoma
- Contribution to journal › Article
-
Mark
Gene expression signature of acquired chemoresistance in neuroblastoma cells
- Contribution to journal › Article
-
Mark
Preclinical investigation of novel therapies against neuroblastoma
(2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma
- Contribution to journal › Article
- 2019
-
Mark
Multidimensional intratumour heterogeneity in neuroblastoma
- Contribution to journal › Debate/Note/Editorial
-
Mark
Hypoxia and Stem Cells in Normal and Tumor Development
- Thesis › Doctoral thesis (compilation)
-
Mark
Engineered human mesenchymal stem cells for neuroblastoma therapeutics
- Contribution to journal › Article
-
Mark
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
- Contribution to journal › Article
